Literature DB >> 10722514

Coordinate suppression of superantigen-induced cytokine production and T-cell proliferation by a small nonpeptidic inhibitor of class II major histocompatibility complex and CD4 interaction.

T Krakauer1.   

Abstract

Proinflammatory cytokines mediate the toxic effect of superantigenic staphylococcal exotoxins (SE). TJU103, a small nonpeptidic molecule that blocks the interaction between major histocompatibility complex class II and CD4 molecules inhibited SE-stimulated T-cell proliferation (by 92%) and production of tumor necrosis factor, interleukin 1beta, interleukin 6, and gamma interferon (by 66, 56, 76, and 72%, respectively) by human peripheral blood mononuclear cells. These data suggest that TJU103 may be useful for mitigating the pathogenic effects of SE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722514      PMCID: PMC89815          DOI: 10.1128/AAC.44.4.1067-1069.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

Authors:  Y W Choi; B Kotzin; L Herron; J Callahan; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  IL-2, IL-4, and IFN-gamma gene expression versus secretion in superantigen-activated T cells. Distinct requirement for costimulatory signals through adhesion molecules.

Authors:  A S Lagoo; S Lagoo-Deenadayalan; H M Lorenz; J Byrne; W H Barber; K J Hardy
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

3.  A computer screening approach to immunoglobulin superfamily structures and interactions: discovery of small non-peptidic CD4 inhibitors as novel immunotherapeutics.

Authors:  S Li; J Gao; T Satoh; T M Friedman; A E Edling; U Koch; S Choksi; X Han; R Korngold; Z Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

4.  Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.

Authors:  P Scholl; A Diez; W Mourad; J Parsonnet; R S Geha; T Chatila
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Clinical manifestations of toxic shock syndrome.

Authors:  P J Chesney; J P Davis; W K Purdy; P J Wand; R W Chesney
Journal:  JAMA       Date:  1981-08-14       Impact factor: 56.272

Review 6.  Superantigens and their potential role in human disease.

Authors:  B L Kotzin; D Y Leung; J Kappler; P Marrack
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

7.  Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release.

Authors:  B G Stiles; S Bavari; T Krakauer; R G Ulrich
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.

Authors:  J Parsonnet; R K Hickman; D D Eardley; G B Pier
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

9.  CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation.

Authors:  J D Fraser; M E Newton; A Weiss
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

10.  T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.

Authors:  T Miethke; C Wahl; K Heeg; B Echtenacher; P H Krammer; H Wagner
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  1 in total

1.  Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo.

Authors:  Stacey X Xu; Kevin J Gilmore; Peter A Szabo; Joseph J Zeppa; Miren L Baroja; S M Mansour Haeryfar; John K McCormick
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.